Patients, payers, and hospitals need rigorous, data-driven measures to help optimize decision-making. As consumers of health care, patients and families may select options that maximize safety, outcomes, convenience, cost, timeliness, efficacy, and equity.1 Payers use value equations that optimize costs while maximizing outcomes. Hospitals must minimize utilization metrics, including length of stay and 30-day readmission rates, to avoid financial penalty.2 In this issue of JAMA Otolaryngology–Head & Neck Surgery, Dixon et al3 have managed to provide all 3 groups with key information about excess hospital time after vestibular schwannoma surgery. This crucial study examined the National Cancer Database over a 16-year period to evaluate excess hospital utilization, a composite of length of stay variance or 30-day readmissions. Rather than subjective categorization by hospital volume, facility volume was defined by the mean number of vestibular schwannoma cases per year. In a unique contribution to our field, the authors empirically determined the cutoff values for case numbers rather than using subjective or arbitrary cutoff values to define facility volume. This method defined an annual volume of 25 cases per year as the threshold for reduced risk of prolonged hospitalization or 30-day readmissions. This robust study methodology and findings have important implications for patients, payers, and hospitals.